Nightingale Health
1.68 EUR
-0.71 %
4,672 following
Corporate customer
HEALTH
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Investor consensus
-0.71 %
-14.72 %
-18.05 %
-28.66 %
-29.41 %
-39.35 %
+62.48 %
-
-67.38 %
Nightingale Health operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes platforms and services within blood analysis that are used for disease prevention purposes. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe.
Read moreMarket cap
102.38M EUR
Turnover
57.94K EUR
P/E (adj.) (26e)
-6.17
EV/EBIT (adj.) (26e)
-3.73
P/B (26e)
1.95
EV/S (26e)
8.23
Dividend yield-% (26e)
-
Coverage
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
5.3
2026
Interim report Q2'26
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Inside information: Nightingale Health achieves major milestone in the United States: New York laboratory now holds a clinical laboratory permit from New York State
Another welfare services country is piloting Nightingale's technology
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools










